Observation of lenalidomide combined with modified MP regimen in the treatment of elderly patients with multiple myeloma
10.3760/cma.j.issn.1008?6315.2018.02.003
- VernacularTitle:雷利度胺联合改良MP方案治疗老年多发性骨髓瘤患者的效果观察
- Author:
Qingrong LIU
1
;
Wei LI
Author Information
1. 063000,河北省唐山市工人医院血液科
- Keywords:
Lenalidomide;
MP regimen;
Multiple myeloma;
Elderly;
β2 microglobulin
- From:Clinical Medicine of China
2018;34(2):115-117
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the clinical effect of lenalidomide combined with modified MP regimen in the treatment of multiple myeloma( MM) . Methods Eighty=four elderly multiple myeloma patients treated in Tangshan City Workers'Hospital from January 2013 December 2016 were enrolled in this study. The patients were randomly divided into treatment group ( 42 cases) and control group ( 42 cases) . The patients in the treatment group were given LMP regimen +α2b? interferon. The patients in the control group received the standard MPT regimen. The changes of the level of β2 microglobulin in the two groups before and after treatment were compared,and the total effective rate in the two groups was compared. Results No statistically significant difference was showed between the two groups in β2 microglobulin before treatment ( P>0. 05) . After treatment,β2 microglobulin concentration in the treatment group was (3. 11±0. 28) and was (4. 75±0. 36) in the control group,there was significant difference between two groups ( t=9. 094,P<0. 05); the total effective rate of the treatment group was 83. 33％,59. 52％ in the control group,there was significant difference between two groups ( t=5. 833,P=0. 016) . The incidence of adverse reactions in the treatment group was 9. 52％,the control group was 26. 19％,and the two groups were statistically significant ( t=3. 977,P=0. 046) . Conclusion The clinical effect of Lenalidomide combined with modified MP regimen in the treatment of MM is better than that of conventional treatment,the total effective rate is highwe,with less adverse reactions.
